Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia.
He BL, Yang N, Man CH, Ng NK, Cher CY, Leung HC, Kan LL, Cheng BY, Lam SS, Wang ML, Zhang CX, Kwok H, Cheng G, Sharma R, Ma AC, So CW, Kwong YL, Leung AY.
He BL, et al. Among authors: man ch.
EMBO Mol Med. 2020 Apr 7;12(4):e10895. doi: 10.15252/emmm.201910895. Epub 2020 Mar 5.
EMBO Mol Med. 2020.
PMID: 32134197
Free PMC article.